Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D000287:Administration, Topical; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D001564:Benzo(a)pyrene / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism; D002273:Carcinogens / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D002417:Cattle; D004247:DNA / Q000037:antagonists & inhibitors* / Q000302:isolation & purification / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005937:Glucaric Acid / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D012867:Skin / Q000187:drug effects* / Q000378:metabolism; D013937:Thymidine Kinase / Q000378:metabolism / Q000494:pharmacology; D013950:Thymus Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002273:Carcinogens; D014316:Tritium; D001564:Benzo(a)pyrene; D015127:9,10-Dimethyl-1,2-benzanthracene; D004247:DNA; D001189:Aryl Hydrocarbon Hydroxylases; D013937:Thymidine Kinase; D005937:Glucaric Acid